Anal Cancer, Cancer, HPV, HPV 16 Infection, HPV Infection, Human Papillomavirus Infection, Men
Conditions
Keywords
Vaccination, Vaccine, Public health, Prevention, Men who have sex with men, Gay and bisexual men, Immunisation
Brief summary
Anal cancer is overrepresented among gay, bisexual and other men who have sex with men (MSM), particularly those living with HIV. Australia was the first country to introduce a publicly funded national HPV vaccination program in 2007. This program was expanded to include schoolboys aged 12-13 years in 2013; with a 2-year catch-up for boys aged up to 15 years. The goal of the HYPER4 study is to determine the prevalence of anal, genital and oral HPV among 500 young gay and bisexual men aged 21-25 years who were eligible for the school-based gender-neutral quadrivalent vaccination program. Participants will be required to complete a questionnaire and provide samples for HPV testing. No follow-up visits will be required.
Interventions
None listed
Sponsors
Monash University
The Alfred
University of Melbourne
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
MALE
Age
21 Years to 25 Years
Inclusion criteria
* Men aged 21 to 25 years old in 2023-2024 * Same-sex attracted * Residing in Australia since 2013
Exclusion criteria
* Unable to complete all study requirements in English
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of quadrivalent vaccine HPV types | Baseline | The oral, penile and anal prevalence of quadrivalent vaccine types (6, 11, 16 and 18) |
| Prevalence of type-specific HPV types | Baseline | The oral, penile and anal prevalence of type-specific HPV types |
Countries
Australia
Contacts
Primary ContactEric Chow, PhD
Outcome results
None listed